# Anti-Snoring Device Market

> Anti Snoring Device Market Research Report By Device Type (Oral Appliances, Nasal Dilators, Positional Sleep Therapy, Surgery), By Distribution Channel (Online, Retail, Hospital), By End User (Individuals, Clinics, Hospitals, Other healthcare facilities), By Severity of Snoring (Mild, Moderate, Severe) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 10.32%
- **2024:** $ 15.32 Billion
- **2025:** $ 16.9 Billion
- **2035:** $ 45.13 Billion
- **Key Players:** Companies such as SnoreRx(US), ZQuiet (US), VitalSleep (US), Mouthpiece (US), SleepTight (US), AirSnore (GB), Good Morning Snore Solution (CA), Breathe Right (US) are some of the major participants in the market.

**Report ID:** MRFR/HC/28000-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** May 29, 2026

**URL:** https://www.marketresearchfuture.com/reports/anti-snoring-device-market-29729

---

## Market Summary

## **Anti Snoring Device Market Overview**

As per MRFR analysis, the Anti-Snoring Device Market Size was estimated at 15.32 (USD Billion) in 2024. The Anti-Snoring Device Market Industry is expected to grow from 16.90 (USD Billion) in 2025 to 40.91 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 10.32% during the forecast period (2025 - 2034).

Source Primary Research, Secondary Research, MRFR Database and Analyst Review

### **Key Anti-snoring Device Market Trends Highlighted**

The market for Anti-snoring devices is witnessing significant growth, driven by the rising prevalence of sleep disorders. The increasing awareness of the health risks associated with snoring, such as cardiovascular issues and sleep deprivation, is fueling the demand for these devices.

Furthermore, the advancement of technological innovations has led to the development of more effective and user-friendly Anti-snoring solutions.

Key market drivers include the increasing adoption of smartphone-connected sleep-tracking devices, which monitor sleep patterns and provide personalized insights into snoring habits. The growing popularity of minimally invasive and non-invasive Anti-snoring treatments, such as oral appliances and nasal dilators, is also driving market expansion.

Additionally, the rising demand for over the counter (OTC) Anti-snoring products is expected to contribute to the market's growth in the coming years.

Opportunities for growth lie in the development of advanced Anti-snoring devices that incorporate artificial intelligence and machine learning algorithms to provide personalized and adaptive treatments.

The integration of these technologies can enhance the effectiveness and convenience of Anti-snoring solutions, making them more appealing to consumers. Additionally, exploring new distribution channels, such as online marketplaces and pharmacies, can expand the reach and accessibility of Anti-snoring devices.

## **Anti-snoring Device Market Drivers**

### **Rising Prevalence of Snoring and Sleep Apnea**

Snoring and sleep apnea are highly prevalent worldwide, affecting a significant portion of the population. The increasing prevalence of these conditions is primarily attributed to factors such as obesity, aging, and unhealthy lifestyle choices.

As the number of individuals affected by snoring and sleep apnea grows, the demand for effective Anti-snoring devices is expected to rise in tandem. The  Anti-snoring Device Market Industry is anticipated to experience substantial growth due to the increasing prevalence of these sleep disorders.

### **Technological Advancements and Innovation**

Technological advancements have played a crucial role in the development of innovative and effective Anti-snoring devices. Manufacturers are continuously investing in research and development to introduce advanced devices with improved functionality, comfort, and efficacy.

These advancements include the integration of sensors, Bluetooth connectivity, and smartphone applications, which provide users with personalized insights into their sleep patterns and snoring habits.

The Anti-snoring Device Market Industry is expected to benefit significantly from ongoing technological innovations.

### **Growing Awareness and Accessibility**

Increased awareness about the negative health effects of snoring and sleep apnea has led to a greater demand for Anti-snoring devices. Public health campaigns and educational initiatives have played a vital role in raising awareness about the importance of addressing these conditions.

Additionally, improved accessibility to Anti-snoring devices through various distribution channels, including online retailers and pharmacies, has contributed to the growth of the  Anti-snoring Device Market Industry.

## **Anti-snoring Device Market Segment Insights**

### **Anti-snoring Device Market Device Type Insights**

Device Type Segment Overview in the  Anti-snoring Device Market The  Anti-snoring device market is segmented by device type into oral appliances, nasal dilators, positional sleep therapy, and surgery.

Oral appliances held the largest market share in 2023, accounting for nearly half of the  revenue. The growth of this segment is driven by the increasing prevalence of sleep apnea and snoring disorders, as well as rising awareness about the benefits of oral appliances in treating these conditions. Nasal dilators are expected to witness the highest CAGR during the forecast period.

The increasing popularity of nasal dilators as a less invasive and more affordable alternative to oral appliances is contributing to the segment's growth. Positional sleep therapy devices are gaining traction due to their ability to prevent snoring by keeping the user in a non-supine position during sleep.

Surgery is the most invasive and expensive treatment option for snoring, but it remains a viable option for severe cases where other methods have failed.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Anti-snoring Device Market Distribution Channel Insights**

The distribution channel segment of the  Anti-snoring Device Market plays a crucial role in making these devices accessible to consumers. Online channels, including e-commerce platforms and company websites, have gained significant traction in recent years, offering convenience, a wide product selection, and competitive pricing.

In 2023, the online distribution channel accounted for approximately 35% of the  Anti-snoring Device Market revenue. Major players in the online segment include Amazon, CVS Health, and Walgreens. Retail channels, such as pharmacies, drug stores, and medical equipment stores, continue to hold a strong position in the market.

Consumers prefer these channels for the ability to physically examine products, receive professional advice, and make immediate purchases. In 2023, the retail segment captured around 40% of the  Anti-snoring Device Market revenue.

Leading retail chains include Walmart, Target, and Boots. Hospitals and clinics represent another important distribution channel for Anti-snoring devices.

Healthcare professionals often recommend and prescribe these devices to patients suffering from sleep apnea or snoring issues. In 2023, the hospital segment accounted for approximately 25% of the  Anti-snoring Device Market revenue.

### **Anti-snoring Device Market End User Insights**

The End User segment of the  Anti-snoring Device Market encompasses Individuals, Clinics, Hospitals, and other healthcare facilities. Among these, Individuals hold the dominant market share, primarily driven by the increasing prevalence of snoring disorders and the convenience of over-the-counter Anti-snoring devices.

Clinics and hospitals are also significant end users, leveraging Anti-snoring devices for diagnostic and therapeutic purposes. Other healthcare facilities, such as sleep clinics and dental offices, contribute to the market growth by providing specialized Anti-snoring treatments and devices tailored to patients' specific needs and preferences.

### **Anti-snoring Device Market Severity of Snoring Insights**

The Anti-snoring Device Market is segmented by the severity of snoring, which includes mild, moderate, and severe. The market for mild snoring is expected to witness significant growth owing to the high prevalence of this condition.

According to the American Academy of Otolaryngology-Head and Neck Surgery, around 45% of adults experience mild snoring. The market for moderate snoring is also expected to grow steadily, as it is estimated that 25% of adults experience moderate snoring. The market for severe snoring is expected to have the highest growth rate, as it is estimated that 10% of adults experience severe snoring.

This growth is attributed to the increasing awareness of the health risks associated with severe snoring, such as sleep apnea and cardiovascular disease.

### **Anti-snoring Device Market Regional Insights**

The Anti-snoring Device Market is segmented into North America, Europe, APAC, South America, and MEA. Among these regions, North America is the largest market for Anti-snoring devices, followed by Europe and APAC.

The growth in the North American market is attributed to the rising prevalence of sleep disorders, growing awareness about the health risks associated with snoring, and increasing disposable income. The European market is also expected to witness significant growth due to increasing healthcare expenditure and growing adoption of advanced Anti-snoring devices.

The APAC region is expected to be the fastest-growing market for Anti-snoring devices, driven by the rising prevalence of sleep disorders and increasing disposable income in countries such as China and India. The South American and MEA markets are expected to witness moderate growth due to limited healthcare infrastructure and lower awareness about Anti-snoring devices.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Anti-snoring Device Market Key Players and Competitive Insights**

Major players in the Anti-snoring Device Market are constantly striving to enhance their product portfolio and strengthen their market position. For instance, in 2024, ResMed introduced the AirMini AutoSet, a compact and portable CPAP machine designed for travel and home use.

Philips Respironics launched DreamMapper, a cloud-based patient management platform that allows users to track their sleep therapy data and connect with their healthcare providers.

Leading Anti-snoring Device Market players like Somnifix and Rhinomed are focused on developing innovative products. Somnifix offers a range of nasal strips and mouth tapes designed to reduce snoring and improve sleep quality. Rhinomed's Rhinomed Turbine is a drug-free nasal dilator that helps improve airflow and reduce nasal congestion.

Anti-snoring Device Market development is driven by factors such as rising awareness about the negative effects of snoring, advancements in medical technology, and the growing prevalence of sleep disorders.

Key Anti-snoring Device Market industry participants are focusing on expanding their presence in emerging markets, such as Asia-Pacific and Latin America, where the demand for Anti-snoring devices is growing rapidly.

### **Key Companies in the Anti-snoring Device Market Include**

## Anti-snoring Device Market Industry Developments

- **Q1 2024: ProSomnus Announces FDA Clearance of ProSomnus EVO Select™ Oral Appliance for Snoring and Obstructive Sleep Apnea** ProSomnus received FDA 510(k) clearance for its EVO Select™ oral appliance, expanding its portfolio of devices for the treatment of snoring and obstructive sleep apnea.
- **Q2 2024: ResMed Launches AirFit F40, Its Smallest Full Face CPAP Mask, to Address Snoring and Sleep Apnea** ResMed announced the commercial launch of the AirFit F40, a new full face CPAP mask designed to improve comfort and compliance for patients with snoring and sleep apnea.
- **Q2 2024: Vivos Therapeutics Announces Strategic Partnership with Ormco to Expand Access to Anti-Snoring Oral Appliances** Vivos Therapeutics entered a strategic partnership with Ormco, a global dental company, to expand the distribution and adoption of its oral appliances for snoring and sleep apnea.
- **Q2 2024: SomnoMed Appoints Neil Verdal-Austin as CEO to Drive Global Expansion of Anti-Snoring Devices** SomnoMed announced the appointment of Neil Verdal-Austin as Chief Executive Officer, aiming to accelerate the company's global growth in the anti-snoring and sleep apnea device market.
- **Q3 2024: ProSomnus Announces Opening of New Manufacturing Facility in Pleasanton, California** ProSomnus opened a new manufacturing facility in Pleasanton, California, to increase production capacity for its anti-snoring and sleep apnea oral appliances.
- **Q3 2024: Vivos Therapeutics Receives Health Canada Approval for Vivos CARE Oral Appliance for Snoring and Sleep Apnea** Vivos Therapeutics received regulatory approval from Health Canada for its Vivos CARE oral appliance, enabling commercial sales in the Canadian market.
- **Q3 2024: SomnoMed Launches SomnoDent Avant, a Next-Generation Oral Appliance for Snoring and Sleep Apnea** SomnoMed launched the SomnoDent Avant, a new oral appliance designed to improve patient comfort and treatment efficacy for snoring and obstructive sleep apnea.
- **Q4 2024: Vivos Therapeutics Announces $15 Million Private Placement to Accelerate Commercialization of Anti-Snoring Devices** Vivos Therapeutics completed a $15 million private placement financing to support the commercialization and distribution of its anti-snoring and sleep apnea devices.
- **Q4 2024: ProSomnus Announces Partnership with SleepQuest to Expand Access to Oral Appliance Therapy for Snoring** ProSomnus entered a partnership with SleepQuest, a sleep care management company, to expand patient access to oral appliance therapy for snoring and sleep apnea.
- **Q1 2025: ResMed Acquires Somnowell to Broaden Anti-Snoring and Sleep Apnea Solutions Portfolio** ResMed announced the acquisition of Somnowell, a UK-based provider of custom oral appliances for snoring and sleep apnea, to strengthen its product offerings in the sector.
- **Q2 2025: Vivos Therapeutics and Henry Schein Announce Distribution Agreement for Anti-Snoring Oral Appliances** Vivos Therapeutics signed a distribution agreement with Henry Schein, a leading global healthcare solutions company, to expand the reach of its anti-snoring oral appliances.
- **Q2 2025: ProSomnus Raises $20 Million in Series C Funding to Scale Production of Anti-Snoring Devices** ProSomnus completed a $20 million Series C funding round to increase manufacturing capacity and accelerate the commercialization of its anti-snoring and sleep apnea devices.

## **Anti-snoring Device Market Segmentation Insights**

### **Anti-snoring Device Market Device Type Outlook**

### **Anti-snoring Device Market Distribution Channel Outlook**

### **Anti-snoring Device Market End User Outlook**

### **Anti-snoring Device Market Severity of Snoring Outlook**

### **Anti-snoring Device Market Regional Outlook**

## Market Drivers

### Aging Population

The Anti Snoring Device Market is significantly impacted by the aging population, which tends to experience higher rates of snoring and sleep apnea. As individuals age, physiological changes can lead to increased airway resistance, making snoring more prevalent. This demographic shift is prompting a greater demand for anti-snoring devices, as older adults seek solutions to improve their sleep quality and overall health.
 
With the global population aged 60 and above projected to reach 2 billion by 2050, the market is likely to expand in response to this growing segment. The increasing awareness of sleep health among older adults may further drive the adoption of anti-snoring devices, potentially leading to a market growth rate of around 8% in the coming years.
 

- World Bank demographic data indicate that the global population aged 65 years and older continues to increase steadily, creating a larger consumer base susceptible to snoring and sleep apnea, thereby supporting long-term demand for anti-snoring devices and sleep management solutions.

### Diverse Product Offerings

The Anti Snoring Device Market is characterized by a diverse range of product offerings, catering to various consumer preferences and needs. From nasal strips to mouthpieces and positional therapy devices, the variety allows consumers to select products that best suit their individual requirements. This diversity not only enhances consumer choice but also stimulates competition among manufacturers, leading to continuous innovation and improvement in product quality.
 
As a result, the market is likely to see an increase in sales, with projections indicating a growth rate of approximately 9% in the next five years. The availability of multiple options ensures that consumers can find effective solutions tailored to their specific snoring issues.
 

- PubMed studies demonstrate that mandibular advancement devices significantly improve snoring symptoms and sleep quality in many patients, supporting continued product diversification and expanding consumer adoption of non-invasive anti-snoring therapies.

### Increased Health Awareness

The Anti Snoring Device Market is witnessing a notable increase in health awareness among consumers, which is driving the demand for effective anti-snoring solutions. As individuals become more conscious of the health implications associated with snoring, such as cardiovascular issues and daytime fatigue, they are more inclined to invest in devices that promise better sleep quality.
 
This heightened awareness is further fueled by educational campaigns and health initiatives that emphasize the importance of sleep hygiene. Consequently, the market is projected to grow as consumers prioritize their health and well-being, with an estimated growth rate of 7% anticipated over the next few years.
 

- IHME data identify sleep-related disorders as an important contributor to reduced health outcomes and quality of life, encouraging greater public awareness and supporting increased utilization of anti-snoring interventions and sleep health products.

### Technological Advancements

The Anti Snoring Device Market is experiencing a surge in technological advancements, which enhances the efficacy and user experience of these devices. Innovations such as smart sensors and mobile applications allow for real-time monitoring of snoring patterns, providing users with personalized feedback. This integration of technology not only improves the functionality of anti-snoring devices but also appeals to a tech-savvy consumer base.
 
As a result, the market is projected to grow at a compound annual growth rate of approximately 8% over the next five years, driven by the demand for more sophisticated solutions. Furthermore, the incorporation of [artificial intelligence](https://www.marketresearchfuture.com/reports/artificial-intelligence-market-1139) in these devices may lead to more effective treatments, thereby expanding the market's reach and potential.
 

- PubMed research highlights growing utilization of digital sleep-monitoring technologies and wearable health devices, enabling personalized treatment approaches and strengthening adoption of technologically advanced anti-snoring solutions.

### Rising Prevalence of Sleep Disorders

The Anti Snoring Device Market is significantly influenced by the rising prevalence of sleep disorders, particularly obstructive sleep apnea and chronic snoring. According to health statistics, nearly 30% of adults experience some form of sleep disruption, which has led to an increased demand for effective solutions. This growing awareness of sleep-related health issues has prompted consumers to seek out anti-snoring devices as viable alternatives to traditional treatments.
 
The market is likely to benefit from this trend, as more individuals recognize the importance of quality sleep for overall health. Consequently, the demand for anti-snoring devices is expected to rise, potentially leading to a market expansion of around 10% in the coming years.
 

- IHME estimates show sleep disorders affect millions globally, with prevalence increasing alongside obesity and aging populations, creating substantial opportunities for anti-snoring device manufacturers and sleep therapy providers.

## Future Outlook

The Anti Snoring Device Industry size is projected to reach USD 45.13 Billion by 2035, growing at a CAGR of 10.32%, driven by increasing awareness of sleep disorders and technological advancements.

**New opportunities:**

- Development of smart anti-snoring devices with integrated sleep tracking features. Expansion into emerging markets through localized product offerings. Partnerships with healthcare providers for integrated treatment solutions.

By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in sleep health solutions.

## Segment Insights

### By Type: Oral Appliances (Largest) vs. Nasal Dilators (Fastest-Growing)

The Anti Snoring Device Market is primarily driven by a diverse range of products categorized under four main types: Oral Appliances, Nasal Dilators, Positional Sleep Therapy, and Surgery. Among these, Oral Appliances command the largest market share of 48%, as they are widely embraced for their effectiveness and ease of use. Nasal Dilators, while still a significant contributor, represent the fastest-growing segment owing to increased awareness and adoption of non-invasive solutions. This segmentation reflects consumer preferences for comfort and convenience in addressing snoring issues.

SnoreRx continues enhancing adjustable oral appliance technology designed to improve airway positioning during sleep. Oral appliances accounted for approximately 48% of the Anti-Snoring Device Market in 2024, supported by strong clinical acceptance, ease of use, and growing preference for non-invasive treatment options.

### By Distribution Channel: Online (Largest) vs. Retail (Fastest-Growing)

In the Anti Snoring Device Market, the distribution predominantly leans towards the online channel, which captures the largest share of 57% of sales. This can be attributed to the convenience and accessibility that online shopping offers consumers, allowing for easy comparisons, reviews, and purchases from the comfort of their homes. Meanwhile, the retail sector also holds a significant portion of the market, appealing to consumers who prefer to see products in person and receive immediate assistance from store staff.

ZQuiet leverages direct-to-consumer digital sales channels to expand accessibility and product awareness. Online distribution represented approximately 57% of market revenue in 2024, reflecting consumer preference for convenience, product comparisons, and home delivery of sleep health solutions.

### By End User: Individuals (Largest) vs. Clinics (Fastest-Growing)

In the Anti Snoring Device Market, the distribution of market share across different end users shows individuals as the largest segment, comprising a significant 68% of the market share. This is largely due to the increasing awareness of sleep apnea and snoring issues among consumers, leading more individuals to seek solutions for better sleep quality. Conversely, clinics represent the fastest-growing segment, as they increasingly adopt advanced anti-snoring technologies to provide personalized treatment solutions for their patients. The growth trends in this segment are fueled by rising incidences of sleep disorders and a growing focus on healthcare quality. Individuals are motivated by personal health awareness, while clinics are expanding their services with innovative devices. This trend is anticipated to persist as more healthcare providers seek to address the growing demand for effective anti-snoring solutions in their practices.

Individuals (Dominant) vs. Clinics (Emerging)

Individuals, as the dominant segment in the Anti Snoring Device Market, tend to prefer consumer-focused solutions that are accessible and easy to use at home. This segment is characterized by high awareness and self-management of sleep issues, leading to a demand for user-friendly devices. On the other hand, clinics represent an emerging segment that is actively integrating new anti-snoring technologies into their treatment protocols. These facilities focus on customized therapies, utilizing devices that provide patient-specific solutions. The collaboration between technology developers and clinics enhances the growth potential of this segment, as clinics aim to provide holistic care guided by the latest advancements in sleep medicine.

### By Severity of Snoring: Moderate (Largest) vs. Severe (Fastest-Growing)

In the Anti Snoring Device Market, the distribution of market share among different severity levels of snoring shows that moderate snoring takes the lead holding market share of 44%. This segment is widely acknowledged for its significant impact on sleep quality, making it a priority for consumers seeking effective remedies. The mild snoring segment follows closely, appealing to a broad audience looking for preventive solutions. Conversely, the severe snoring category has been identified as the fastest-growing segment, propelled by heightened awareness of health issues associated with severe snoring, including sleep apnea. The growth trends reflect a growing consumer inclination towards comprehensive sleep solutions. As health-conscious individuals increasingly recognize the negative effects of severe snoring on overall wellbeing, demand for devices catering to this group has surged. Furthermore, advancements in technology are tipping the balance, enabling manufacturers to deliver innovative solutions that resonate with the needs of moderate and severe snorers alike. A rising number of people are actively seeking devices that promise improved sleep quality and overall health benefits, contributing to the dynamic expansion of this market.

Moderate (Dominant) vs. Severe (Emerging)

In the Anti Snoring Device Market, moderate snoring stands out as the dominant severity category. This segment is characterized by a broad demographic appeal, attracting consumers who experience disrupted sleep but are yet to reach a critical level of severity. Products targeting moderate snoring often focus on user-friendliness, effectiveness, and comfortable design, meeting the needs of a diverse range of customers. On the other hand, severe snoring, while currently emerging, is gaining momentum rapidly. This segment is driven by increasing health concerns and a growing acknowledgment of its links with serious health issues like sleep apnea. As awareness spreads, manufacturers are innovating to address the specific requirements of severe snorers, fostering an environment for rapid growth and market expansion.

## Regional Market Share Analysis

The Anti-snoring Device Market is segmented into North America, Europe, APAC, South America, and MEA. Among these regions, North America leads in the Anti-Snoring Device Market Size, accounting for over 45.04% of the global revenue in 2024, followed by Europe and APAC.

- CDC data indicate that approximately 1 in 3 U.S. adults do not get sufficient sleep regularly, highlighting substantial demand for sleep improvement solutions and supporting growth opportunities for anti-snoring device manufacturers across North America.

The growth in the North American market is attributed to the rising prevalence of sleep disorders, growing awareness about the health risks associated with snoring, and increasing disposable income. Europe Anti-Snoring Device Market was valued at USD 4.596 billion in 2024, making it the second-largest regional market with a 30% share.

- GE Healthcare continues supporting sleep diagnostics and monitoring technologies through advanced healthcare solutions. Growing investment in sleep disorder diagnosis and patient monitoring is strengthening awareness and facilitating adoption of anti-snoring treatment devices throughout North American healthcare systems.

The APAC region is expected to be the fastest-growing market for Anti-snoring devices, driven by the rising prevalence of sleep disorders and increasing disposable income in countries such as China and India. The South American and MEA markets are expected to witness moderate growth due to limited healthcare infrastructure and lower awareness about Anti-snoring devices.

- The European Medicines Agency (EMA) supports rigorous regulatory standards for medical devices and healthcare technologies. Strong regulatory oversight enhances consumer confidence, encourages innovation in sleep health products, and supports broader adoption of anti-snoring devices across European markets.

## Competitive Benchmarking

Major players in the Anti-snoring Device Market are constantly striving to enhance their product portfolio and strengthen their market position. For instance, in 2024, ResMed introduced the AirMini AutoSet, a compact and portable CPAP machine designed for travel and home use. Philips Respironics launched DreamMapper, a cloud-based patient management platform that allows users to track their sleep therapy data and connect with their healthcare providers. Leading Anti-snoring Device Market players like Somnifix and Rhinomed are focused on developing innovative products. Somnifix offers a range of nasal strips and mouth tapes designed to reduce snoring and improve sleep quality.
 
Rhinomed's Rhinomed Turbine is a drug-free nasal dilator that helps improve airflow and reduce nasal congestion. Anti-snoring Device Market development is driven by factors such as rising awareness about the negative effects of snoring, advancements in medical technology, and the growing prevalence of sleep disorders. Key Anti-snoring Device Market industry participants are focusing on expanding their presence in emerging markets, such as Asia-Pacific and Latin America, where the demand for Anti-snoring devices is growing rapidly.

## Recent News & Developments

- **Q1 2024: ProSomnus Announces FDA Clearance of ProSomnus EVO Select™ Oral Appliance for Snoring and Obstructive Sleep Apnea** ProSomnus received FDA 510(k) clearance for its EVO Select™ oral appliance, expanding its portfolio of devices for the treatment of snoring and obstructive sleep apnea.
- **Q2 2024: ResMed Launches AirFit F40, Its Smallest Full Face CPAP Mask, to Address Snoring and Sleep Apnea** ResMed announced the commercial launch of the AirFit F40, a new full face CPAP mask designed to improve comfort and compliance for patients with snoring and sleep apnea.
- **Q2 2024: Vivos Therapeutics Announces Strategic Partnership with Ormco to Expand Access to Anti-Snoring Oral Appliances** Vivos Therapeutics entered a strategic partnership with Ormco, a global dental company, to expand the distribution and adoption of its oral appliances for snoring and sleep apnea.
- **Q2 2024: SomnoMed Appoints Neil Verdal-Austin as CEO to Drive Global Expansion of Anti-Snoring Devices** SomnoMed announced the appointment of Neil Verdal-Austin as Chief Executive Officer, aiming to accelerate the company's global growth in the anti-snoring and sleep apnea device market.
- **Q3 2024: ProSomnus Announces Opening of New Manufacturing Facility in Pleasanton, California** ProSomnus opened a new manufacturing facility in Pleasanton, California, to increase production capacity for its anti-snoring and sleep apnea oral appliances.
- **Q3 2024: Vivos Therapeutics Receives Health Canada Approval for Vivos CARE Oral Appliance for Snoring and Sleep Apnea** Vivos Therapeutics received regulatory approval from Health Canada for its Vivos CARE oral appliance, enabling commercial sales in the Canadian market.
- **Q3 2024: SomnoMed Launches SomnoDent Avant, a Next-Generation Oral Appliance for Snoring and Sleep Apnea** SomnoMed launched the SomnoDent Avant, a new oral appliance designed to improve patient comfort and treatment efficacy for snoring and obstructive sleep apnea.
- **Q4 2024: Vivos Therapeutics Announces $15 Million Private Placement to Accelerate Commercialization of Anti-Snoring Devices** Vivos Therapeutics completed a $15 million private placement financing to support the commercialization and distribution of its anti-snoring and sleep apnea devices.
- **Q4 2024: ProSomnus Announces Partnership with SleepQuest to Expand Access to Oral Appliance Therapy for Snoring** ProSomnus entered a partnership with SleepQuest, a sleep care management company, to expand patient access to oral appliance therapy for snoring and sleep apnea.
- **Q1 2025: ResMed Acquires Somnowell to Broaden Anti-Snoring and Sleep Apnea Solutions Portfolio** ResMed announced the acquisition of Somnowell, a UK-based provider of custom oral appliances for snoring and sleep apnea, to strengthen its product offerings in the sector.
- **Q2 2025: Vivos Therapeutics and Henry Schein Announce Distribution Agreement for Anti-Snoring Oral Appliances** Vivos Therapeutics signed a distribution agreement with Henry Schein, a leading global healthcare solutions company, to expand the reach of its anti-snoring oral appliances.
- **Q2 2025: ProSomnus Raises $20 Million in Series C Funding to Scale Production of Anti-Snoring Devices** ProSomnus completed a $20 million Series C funding round to increase manufacturing capacity and accelerate the commercialization of its anti-snoring and sleep apnea devices.

## Report Scope

| MARKET SIZE 2024 | 15.32(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 16.9(USD Billion) |
| MARKET SIZE 2035 | 45.13(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.32% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | SnoreRx (US), ZQuiet (US), VitalSleep (US), Mouthpiece (US), SleepTight (US), AirSnore (GB), Good Morning Snore Solution (CA), Breathe Right (US) |
| Segments Covered | Device Type, Distribution Channel, End User, Severity of Snoring, Regional |
| Key Market Opportunities | Integration of smart technology in Anti Snoring Devices enhances user experience and market potential. |
| Key Market Dynamics | Rising consumer awareness drives demand for innovative anti-snoring devices, influencing competitive dynamics and market growth. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Anti Snoring Device Market?**
A: The market valuation reached 15.32 USD Billion in 2024.

**Q: What is the projected market size for the Anti Snoring Device Market by 2035?**
A: The market is expected to grow to 45.13 USD Billion by 2035.

**Q: What is the expected CAGR for the Anti Snoring Device Market during the forecast period?**
A: The market is projected to experience a CAGR of 10.32% from 2025 to 2035.

**Q: Which segments are included in the Anti Snoring Device Market?**
A: Key segments include Oral Appliances, Nasal Dilators, Positional Sleep Therapy, and Surgery.

**Q: What are the projected valuations for Oral Appliances in the Anti Snoring Device Market?**
A: Oral Appliances are expected to range from 5.0 to 15.0 USD Billion during the forecast period.

**Q: How does the distribution channel impact the Anti Snoring Device Market?**
A: The Retail segment is projected to grow significantly, with valuations expected between 7.0 and 20.0 USD Billion.

**Q: Who are the key players in the Anti Snoring Device Market?**
A: Prominent players include SnoreRx, ZQuiet, VitalSleep, and Good Morning Snore Solution.

**Q: What is the expected performance of the Nasal Dilators segment?**
A: Nasal Dilators are projected to achieve valuations between 3.0 and 9.0 USD Billion.

**Q: How do end-user segments contribute to the market?**
A: Individuals are expected to drive growth, with valuations ranging from 5.0 to 15.0 USD Billion.

**Q: What is the anticipated market performance for severe snoring cases?**
A: The severe snoring segment is projected to reach valuations between 6.11 and 18.14 USD Billion.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/anti-snoring-device-market-29729*